In recent reports the elevated lifetime cancer risk in Cowden syndrome patients or in individuals with germline PTEN mutations is up to 85% for breast cancer, up to 35% for thyroid cancer, and up to 28% for endometrial cancer [5,6]. This evidence concerns the gene PTEN and breast cancer.